Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc > Getting to know SQI Diagnostics....
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(73)
•••
Comment by Scrivs187on Mar 17, 2021 11:46am
120 Views
Post# 32816516

RE:RE:Getting to know SQI Diagnostics....

RE:RE:Getting to know SQI Diagnostics....Hey to each their own i suppose...I guess your posts from 6 years ago with your purchase of untis at .35 has you a tad frustrated as your narrative seems to never change. 4 years ago your comments about "near term potential" has not aged well either....I'd be frustrated too...hows my digging? 
The presentations all look great....for a grade 11 highschool student....time has not been something that has been good for this particular stock and the hush hush vibe certanly doesnt help to bring new investors to the table escpecially with little movement in SP. 

Not really interested in being argumentative with you I just feel as previously mentioned that timelines and time in general will not be super productive for this stock. The previous posters concerns are real...the need for home test kits are there but SQI is not the only player in the field much like the other products they are touting. 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities